BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 1,448,978,913
- Total 13F shares
- 55,475,829
- Share change
- -850,922
- Total reported value
- $15,026,076,469
- Put/Call ratio
- 440%
- Price per share
- $270.93
- Number of holders
- 247
- Value change
- -$242,691,110
- Number of buys
- 110
- Number of sells
- 122
Quarterly Holders Quick Answers
What is CUSIP 07725L102?
CUSIP 07725L102 identifies ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07725L102:
Top shareholders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.81%
|
11,668,897
|
$4,235,810,000 | — | 30 Sep 2021 | |
| AMGEN INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
18,943,802
|
$3,419,356,261 | — | 10 Sep 2021 | |
| Capital International Investors |
13F
|
Company |
0.44%
|
6,323,919
|
$2,295,118,000 | — | 30 Sep 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.38%
|
5,472,259
|
$1,986,430,000 | — | 30 Sep 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.29%
|
4,249,052
|
$1,542,406,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.26%
|
3,812,000
|
$1,383,755,000 | — | 30 Sep 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.26%
|
3,811,347
|
$1,383,519,000 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.21%
|
3,060,292
|
$1,110,886,000 | — | 30 Sep 2021 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.2%
|
2,914,313
|
$1,057,896,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
2,629,542
|
$954,524,000 | — | 30 Sep 2021 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.07%
|
1,012,135
|
$367,405,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
905,082
|
$328,545,000 | — | 30 Sep 2021 | |
| Howard Liang |
3/4/5
|
CFO & Chief Strategy Officer |
—
class O/S missing
|
1,553,149
|
$322,615,606 | — | 28 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.06%
|
850,803
|
$308,841,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.05%
|
764,188
|
$277,400,000 | — | 30 Sep 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.04%
|
650,000
|
$235,950,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.04%
|
570,853
|
$207,220,000 | — | 30 Sep 2021 | |
| PUBLIC INVESTMENT FUND |
13F
|
Company |
0.03%
|
495,389
|
$179,826,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.02%
|
346,341
|
$125,722,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
289,967
|
$105,258,000 | — | 30 Sep 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
248,405
|
$90,171,000 | — | 30 Sep 2021 | |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
244,492
|
$88,751,000 | — | 30 Sep 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
217,547
|
$78,970,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
206,716
|
$74,530,000 | — | 30 Sep 2021 | |
| USS Investment Management Ltd |
13F
|
Company |
0.01%
|
181,844
|
$66,074,000 | — | 30 Sep 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.01%
|
180,624
|
$65,566,512 | — | 30 Sep 2021 | |
| Bridgewater Associates, LP |
13F
|
Company |
0.01%
|
175,923
|
$63,860,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
172,496
|
$62,616,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
163,739
|
$59,437,000 | — | 30 Sep 2021 | |
| Capital Group Private Client Services, Inc. |
13F
|
Company |
0.01%
|
161,980
|
$58,799,000 | — | 30 Sep 2021 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.01%
|
156,925
|
$56,964,000 | — | 30 Sep 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
0.01%
|
150,000
|
$54,450,000 | — | 30 Sep 2021 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.01%
|
145,483
|
$52,810,000 | — | 30 Sep 2021 | |
| Fiera Capital Corp |
13F
|
Company |
0.01%
|
145,239
|
$52,722,000 | — | 30 Sep 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.01%
|
136,281
|
$49,468,000 | — | 30 Sep 2021 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
136,274
|
$49,468,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
127,924
|
$46,436,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
122,680
|
$44,532,000 | — | 30 Sep 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.01%
|
117,170
|
$42,533,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
115,436
|
$41,903,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.01%
|
112,985
|
$41,014,000 | — | 30 Sep 2021 | |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP |
13F
|
Company |
0.01%
|
112,146
|
$40,709,000 | — | 30 Sep 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.01%
|
110,626
|
$40,157,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
110,440
|
$40,088,000 | — | 30 Sep 2021 | |
| Capital International Sarl |
13F
|
Company |
0.01%
|
105,337
|
$38,237,000 | — | 30 Sep 2021 | |
| Amundi |
13F
|
Individual |
0.01%
|
94,831
|
$34,424,000 | — | 30 Sep 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
92,914
|
$33,728,000 | — | 30 Sep 2021 | |
| Jane Huang |
3/4/5
|
CMO, Hematology |
—
mixed-class rows
|
371,331
mixed-class rows
|
$33,246,160 | — | 14 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
86,578
|
$31,428,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.01%
|
85,361
|
$30,986,000 | — | 30 Sep 2021 |
Institutional Holders of BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) as of Q4 2021
As of 31 Dec 2021,
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) was held by
247 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,475,829 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital International Investors, HHLR ADVISORS, LTD., BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, FMR LLC, Invesco Ltd., Temasek Holdings (Private) Ltd, BlackRock Inc., and CAPITAL INTERNATIONAL INC /CA/.
This page lists
249
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
242
Q4 2021 holders
247
Holder diff
5
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.